nifedipine has been researched along with Nervous System Disorders in 10 studies
Nifedipine: A potent vasodilator agent with calcium antagonistic action. It is a useful anti-anginal agent that also lowers blood pressure.
| Excerpt | Relevance | Reference |
|---|---|---|
| " There have been few case reports of adverse events in children." | 5.31 | Evaluation of the safety of short-acting nifedipine in children with hypertension. ( Deming, DD; Egger, DW; Hamada, N; Perkin, RM; Sahney, S, 2002) |
| "The case of a patient who manifested signs and symptoms of previously unsuspected intracranial mass lesions after initiation of nifedipine therapy for control of reflex sympathetic dystrophy is presented." | 3.67 | Symptoms of clinically silent intracranial mass lesions precipitated by treatment with nifedipine. ( Catchings, TT; Higgins, AC; Kelly, DL; Prough, DS, 1985) |
| " There have been few case reports of adverse events in children." | 1.31 | Evaluation of the safety of short-acting nifedipine in children with hypertension. ( Deming, DD; Egger, DW; Hamada, N; Perkin, RM; Sahney, S, 2002) |
| "The nifedipine response was reproduced by isradipine and by verapamil with IC50 values of 9 and 100 nM, respectively." | 1.28 | Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. ( Memo, M; Pizzi, M; Ribola, M; Spano, P; Valerio, A, 1991) |
| " The mean nontoxic dose was 320 mg, whereas the mean toxic ingestion was 3." | 1.28 | Calcium channel blocker toxicity. ( Myers, A; Ramoska, EA; Spiller, HA, 1990) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 4 (40.00) | 18.7374 |
| 1990's | 5 (50.00) | 18.2507 |
| 2000's | 1 (10.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fossati, C | 1 |
| Guistiniani, S | 1 |
| Egger, DW | 1 |
| Deming, DD | 1 |
| Hamada, N | 1 |
| Perkin, RM | 1 |
| Sahney, S | 1 |
| Delbono, O | 1 |
| García, J | 1 |
| Appel, SH | 1 |
| Stefani, E | 1 |
| Andersson, T | 1 |
| Wallén, P | 1 |
| Grillner, S | 1 |
| Norrby, E | 1 |
| Kristensson, K | 1 |
| Pizzi, M | 1 |
| Ribola, M | 1 |
| Valerio, A | 1 |
| Memo, M | 1 |
| Spano, P | 1 |
| Ramoska, EA | 1 |
| Spiller, HA | 1 |
| Myers, A | 1 |
| Belch, JJ | 1 |
| Levenson, JL | 1 |
| Kennedy, K | 1 |
| Catchings, TT | 1 |
| Prough, DS | 1 |
| Kelly, DL | 1 |
| Higgins, AC | 1 |
1 review available for nifedipine and Nervous System Disorders
| Article | Year |
|---|---|
[Side-effects of calcium antagonists].
Topics: Calcium Channel Blockers; Cardiovascular Diseases; Drug Hypersensitivity; Drug Interactions; Fendili | 1984 |
9 other studies available for nifedipine and Nervous System Disorders
| Article | Year |
|---|---|
Evaluation of the safety of short-acting nifedipine in children with hypertension.
Topics: Adolescent; Blood Pressure; Calcium Channel Blockers; Child; Child, Preschool; Dose-Response Relatio | 2002 |
IgG from amyotrophic lateral sclerosis affects tubular calcium channels of skeletal muscle.
Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Calcium Channels; Female; Humans; Immunoglobulin G; Male | 1991 |
A calcium-channel antagonist can prevent paramyxovirus-induced neurodegeneration.
Topics: Animals; Calcium Channel Blockers; Cell Survival; Immunohistochemistry; Mumps; Nervous System Diseas | 1991 |
Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity.
Topics: 3-Pyridinecarboxylic acid, 1,4-dihydro-2,6-dimethyl-5-nitro-4-(2-(trifluoromethyl)phenyl)-, Methyl e | 1991 |
Calcium channel blocker toxicity.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Arrhythmias, Cardiac; Child; Child, Preschool; Delaware; | 1990 |
The phenomenon, syndrome and disease of Maurice Raynaud.
Topics: Antibodies, Antinuclear; Autoantibodies; Blood Circulation; Blood Vessels; Humans; Microcirculation; | 1990 |
[Nifedipine, captopril and labetalol--overviews on the pattern of adverse effects].
Topics: Captopril; Cardiovascular Diseases; Drug Eruptions; Ethanolamines; Gastrointestinal Diseases; Humans | 1985 |
Dysosmia, dysgeusia, and nifedipine.
Topics: Aged; Dysgeusia; Female; Humans; Middle Aged; Nervous System Diseases; Nifedipine; Smell; Taste Diso | 1985 |
Symptoms of clinically silent intracranial mass lesions precipitated by treatment with nifedipine.
Topics: Cerebellar Neoplasms; Humans; Male; Middle Aged; Nervous System Diseases; Nifedipine; Reflex Sympath | 1985 |